H
Hwan Jung Yun
Researcher at Chungnam National University
Publications - 129
Citations - 1893
Hwan Jung Yun is an academic researcher from Chungnam National University. The author has contributed to research in topics: Stromal cell & Cancer. The author has an hindex of 21, co-authored 121 publications receiving 1524 citations. Previous affiliations of Hwan Jung Yun include European Organisation for Research and Treatment of Cancer.
Papers
More filters
Journal ArticleDOI
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes
Sun Min Lim,Hyun Chang,M. J. Yoon,Y. K. Hong,Hyun-Jeong Kim,Woung Youn Chung,Cheong Soo Park,Kee-Hyun Nam,Shin Wook Kang,Min Kyoung Kim,S-W. Kim,Sang Hyub Lee,Hoon Gu Kim,I. I. Na,Yang Soo Kim,Moon Young Choi,Jong Gwang Kim,Keon Uk Park,Hwan Jung Yun,Joo Hang Kim,Byoung Chul Cho +20 more
TL;DR: Everolimus had a limited activity with low response rate in locally advanced or metastatic thyroid cancer and reasonable clinical benefit rate and safety profile may warrant further investigation.
Journal ArticleDOI
A Comparative Trial of a Single Dose of Azithromycin versus Doxycycline for the Treatment of Mild Scrub Typhus
TL;DR: The single 500-mg dose of azithromycin was as effective as the 1-week course of daily 200-mg doses of doxycycline for the treatment of mild scrub typhus acquired in South Korea.
Journal ArticleDOI
Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01): an open-label, phase 3 trial.
Jong-Mu Sun,Ki Hyeong Lee,Sang-We Kim,Dae Ho Lee,Young Joo Min,Hwan Jung Yun,Hoon Kyo Kim,Hong Suk Song,Yeul Hong Kim,Bong-Seog Kim,In Gyu Hwang,Keehyun Lee,Sook Jung Jo,Jae Won Lee,Jae Won Lee,Jin Seok Ahn,Keunchil Park,Myung-Ju Ahn +17 more
TL;DR: Gefitinib was compared with pemetrexed as second‐line therapy in a clinically selected population previously treated with platinum‐based chemotherapy.
Journal ArticleDOI
CXC chemokines and chemokine receptors in gastric cancer: From basic findings towards therapeutic targeting
TL;DR: The roles of CXC chemokines and their receptors in the development, progression, and metastasis of gastric tumors, and their therapeutic potential for gastric cancer are focused on.
Journal ArticleDOI
Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Hyo Jin Lee,Seong-Woo Kim,Ha Yon Kim,Shengjin Li,Hwan Jung Yun,Kyu Sang Song,Samyong Kim,Deog Yeon Jo +7 more
TL;DR: CXCR4 expression is associated with gastric cancer cell migration in vitro, and strong expression of CX CR4 by Gastric cancer cells is significantly associated with lymphatic metastasis in patients with gastrics cancer, suggesting that CXCR 4 plays an important role during gastric cancers progression.